ArticleBlood cancer journal2022

Proteomic profiling based classification of CLL provides prognostication for modern therapy and identifies novel therapeutic targets.

Ti'ara L Griffen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.